Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study (Q35557906)

8 August 2017

Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study (English)

1 reference

8 August 2017

1 reference

1 reference

Haralampos Moutsopoulos

series ordinal

3

object named as

Haralampos M Moutsopoulos

1 reference

PubMed ID

21682863

Athanasios George Tzioufas

8 August 2017

series ordinal

2

object named as

Athanasios G Tzioufas

1 reference

8 August 2017

Katerina Laskari

1

1 reference

8 August 2017

17 June 2011

1 reference

Arthritis Research and Therapy

8 August 2017

1 reference

8 August 2017

13

1 reference

8 August 2017

3

1 reference

8 August 2017

R91

1 reference

https://scigraph.springernature.com/pub.10.1186/ar3366

8 August 2017

0 references

cites work

The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218906

Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218906

Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218906

Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218906

Rapid responses to anakinra in patients with refractory adult-onset Still's disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218906

Blocking IL-1 in systemic inflammation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218906

Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218906

Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218906

A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218906

Etanercept in the treatment of adult patients with Still's disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218906

Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218906

Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218906

Methotrexate treatment in patients with adult onset Still's disease--retrospective study of 13 Japanese cases

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218906

Adult Still's disease: manifestations, disease course, and outcome in 62 patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218906

Preliminary criteria for classification of adult Still's disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218906

Refractory adult onset Still's disease and hypersensitivity to non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors: are biological agents the solution?

12 July 2018

1 reference

Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients.

21 January 2018

1 reference

Decline after immobilisation and recovery after remobilisation of synovial fluid IL1, TIMP, and chondroitin sulphate levels in young beagle dogs

21 January 2018

1 reference

Refractory adult onset Still's disease successfully treated with anakinra

21 January 2018

1 reference

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

21 January 2018

1 reference

Infliximab in the treatment of adult Still's disease refractory to conventional therapy

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218906

Severe systemic inflammatory response syndrome in a patient with adult onset Still's disease treated with the anti-IL1 drug anakinra: a case report

26 September 2018

1 reference

12 December 2020

Effective treatment of steroid refractory adult-onset Still's disease with anakinra

1 reference

12 December 2020

IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease

1 reference

12 December 2020

A case of adult onset Still's disease treated with infliximab

1 reference

12 December 2020

Identifiers

DOI

10.1186/AR3366

1 reference

PubMed ID

21682863

Dimensions Publication ID

8 August 2017

0 references

1 reference

8 August 2017

1 reference

PubMed ID

21682863